A Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With Advanced Lung Cancer
Clinical trial NCT07309276 · RECRUITING
Trial details
- NCT number
- NCT07309276
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-23
- Primary completion
- 2027-11-30
- Enrollment
- 864
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.